Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap USD M1,232Revenue (TTM) USD M507Net Margin (%)9.2Altman Z-Score3.6
Enterprise Value USD M1,228EPS (TTM) USD 1.0Operating Margin %16.0Piotroski F-Score4
P/E(ttm)31.6Beneish M-Score-2.4Pre-tax Margin (%)14.8Higher ROA y-yN
Price/Book2.510-y EBITDA Growth Rate %4.5Quick Ratio4.1Cash flow > EarningsY
Price/Sales2.85-y EBITDA Growth Rate %18.6Current Ratio4.8Lower Leverage y-yY
Price/Free Cash Flow969y-y EBITDA Growth Rate %-22.2ROA % (ttm)4.6Higher Current Ratio y-yN
Dividend Yield %--PEG1.7ROE % (ttm)7.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M40.6ROIC % (ttm)8.7Gross Margin Increase y-yN

Gurus Latest Trades with EBS

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

EBS is held by these investors:



EBS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Bailey SueDirector 2017-01-17Sell19,424$29.780.87view
Havey AdamEVP, Biodefense Divison 2017-01-17Sell8,438$29.750.97view
Abdun-Nabi DanielPresident and CEO 2017-01-10Sell28,240$31.28-3.96view
Richard RonaldDirector 2016-12-13Sell5,900$34.09-11.88view
JOULWAN GEORGE ADirector 2016-06-06Sell4,700$44.12-31.91view
Abdun-Nabi DanielPresident & CEO 2016-06-01Sell8,699$43.74-31.32view
El-Hibri FuadChairman, 10% Owner 2016-05-27Sell9,835$43.5-30.94view
El-Hibri FuadChairman, 10% Owner 2016-05-26Sell39,759$43.13-30.35view
El-Hibri FuadChairman, 10% Owner 2016-05-25Sell85,000$42.52-29.35view
Harsanyi ZsoltDirector 2016-05-25Sell27,867$42.33-29.03view

Press Releases about EBS :

Quarterly/Annual Reports about EBS:

News about EBS:

Articles On GuruFocus.com
Weekly CEO Sales Highlight: Realpage, Anadigics, Emergent BioSolutions, ScanSource Jan 03 2016 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) Nov 05 2010 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) Aug 06 2010 
Emergent BioSolutions Inc. (EBS) President & COO Daniel Abdun-nabi sells 18,150 Shares Jul 30 2010 
Weekly CEO Sells Highlight: Yum! Brands Inc, Marchex Inc, iGate Corp, and Emergent BioSolutions Inc. Jul 25 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 18,800 Shares Jul 23 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 130,100 Shares Jul 22 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 84,433 Shares Jul 19 2010 
Emergent BioSolutions Inc. (EBS) CEO and Chairman, 10% Owner Fuad El-hibri sells 52,000 Shares May 14 2010 
Emergent BioSolutions Inc. Reports Operating Results (10-Q) May 06 2010 

More From Other Websites
Emergent BioSolutions, Inc. :EBS-US: Earnings Analysis: Q4, 2016 By the Numbers : February 27, 2017 Feb 27 2017
Emergent (EBS) Beats Earnings, Revenue Estimates in Q4 Feb 24 2017
Edited Transcript of EBS earnings conference call or presentation 23-Feb-17 10:00pm GMT Feb 23 2017
Emergent Biosolutions posts 4Q profit Feb 23 2017
Emergent Biosolutions posts 4Q profit Feb 23 2017
EMERGENT BIOSOLUTIONS INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Feb 23 2017
Emergent BioSolutions Inc Earnings Call scheduled for 5:00 pm ET today Feb 23 2017
Emergent BioSolutions Reports Fourth Quarter and Twelve Months 2016 Financial Results; Reaffirms... Feb 23 2017
Q4 2016 Emergent BioSolutions Inc Earnings Release - After Market Close Feb 23 2017
EMERGENT BIOSOLUTIONS INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Feb 21 2017
Emergent BioSolutions Receives BARDA Task Order Valued at Up to $30.5 Million to Develop Viral... Feb 13 2017
Emergent BioSolutions to Release Fourth Quarter and Full Year 2016 Financial Results and Conduct a... Feb 09 2017
Emergent BioSolutions Initiates NIAID-Funded Phase 1b Clinical Study to Evaluate Broad-Spectrum... Feb 01 2017
Emergent BioSolutions Receives German Federal Ministry of Health Approval of Building 55 for... Jan 27 2017
Lawsuit for Investors in Shares of Emergent Biosolutions Inc (EBS) Announced by Shareholders... Jan 23 2017
Emergent BioSolutions, Inc. breached its 50 day moving average in a Bearish Manner : EBS-US :... Jan 12 2017
D.C.-area biotech stocks fall on Trump's tough talk on industry Jan 11 2017
Emergent Down on '17 View, Posts Preliminary '16 Results Jan 10 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)